ArticleJIMD reports2025

Farber's Lipogranulomatosis: Multimodal Therapy With Tocilizumab and Consolidative HSCT Improves Assessment, and Long-Term Outcome.

Nathanael C C Lucas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.